• It's like **HCA Healthcare**, but focused on skilled nursing and senior living facilities instead of hospitals.
• The **Marriott** or **Hilton** of skilled nursing and senior living communities.

• Senior Living Services: Pennant operates senior living communities providing residential care, assisted living, and memory care services to seniors.
• Home Health Services: The company offers skilled nursing, physical, occupational, and speech therapy, and other medical services in the comfort of patients' homes.
• Hospice Services: Pennant provides compassionate end-of-life care, pain management, and emotional and spiritual support to terminally ill patients and their families.

Pennant (PNTG)

Pennant (PNTG) primarily serves individuals through its network of senior living communities and skilled nursing facilities. Its major customers can be categorized as follows:

• Senior Living Residents: These individuals seek a residential environment that provides support for daily living. This category includes residents in independent living, assisted living, and memory care communities who require varying levels of assistance with activities of daily living (ADLs) or specialized care for cognitive impairments.
• Skilled Nursing Facility Patients: These individuals require post-acute medical care, rehabilitation services, or long-term skilled nursing care. They typically transition to Pennant's facilities after a hospital stay, surgery, or due to chronic health conditions requiring continuous medical supervision and therapeutic services.

null

Brent Guerisoli Chief Executive Officer

Mr. Guerisoli has served as the Chief Executive Officer of The Pennant Group, Inc. since August 1, 2022, and as Chairman of the Board since January 1, 2025. He was previously the President of Pennant from January 2020. Since joining Pennant in 2012, Mr. Guerisoli has directed growth initiatives across several states and contributed significantly to leadership recruiting, development, and training within the organization. He also led a turnaround in the company's senior living sector. Before becoming President of Pennant, he served as President of Cornerstone, a Pennant subsidiary, starting in 2018. Pennant Group was spun off from The Ensign Group (NASDAQ: ENSG) in 2019.

Lynette Walbom Chief Financial Officer

Ms. Walbom was appointed Chief Financial Officer of The Pennant Group, Inc. effective May 22, 2023. Prior to joining Pennant, she was the vice president of financial reporting and tax for Raising Cane's Restaurants, LLC, where her responsibilities included overseeing acquisitions, accounting systems, and equity management. Before her tenure at Raising Cane's, Ms. Walbom held the position of CFO for a family office investment firm. This firm backed several companies across various industries, including financial services, computer services, real estate development, and franchising.

John J. Gochnour President and Chief Operating Officer

Mr. Gochnour serves as the President and Chief Operating Officer of The Pennant Group, Inc. He was previously the Chief Operating Officer.

Kirk Cheney Executive Vice President

Mr. Cheney holds the title of Executive Vice President at The Pennant Group, Inc. He is also listed as the Executive Vice President, General Counsel, and Corporate Secretary.

Jason Steik Chief Clinical Officer

Mr. Steik is the Chief Clinical Officer for The Pennant Group, Inc.

The rise of highly integrated digital health platforms leveraging artificial intelligence, remote patient monitoring, and advanced virtual care capabilities. These platforms are creating alternative, more efficient, and potentially more preferred models for senior care and home health services, directly challenging traditional, labor-intensive facility-based and in-person home health service delivery. This emerging trend can reduce the demand for traditional facility beds and frequent in-person home health visits by enabling effective care delivery with lower reliance on physical infrastructure and traditional staffing ratios, thereby eroding market share and profitability for conventional providers like Pennant.

The Pennant Group (PNTG) primarily operates in three addressable markets within the United States: home health, hospice care, and senior living services.

Home Health Services

The addressable market for home health services in the U.S. was estimated at approximately $162.35 billion in 2024. This market is projected to grow to approximately $381.40 billion by 2033, with a compound annual growth rate (CAGR) of 10.00% from 2025 to 2033. Other estimates suggest the U.S. home healthcare market size was around $194.24 billion in 2024, expected to reach $222.61 billion by 2025, and projected to be worth approximately $644.37 billion by 2034, at a CAGR of 12.74% from 2025 to 2034.

Hospice Care Services

The U.S. hospice market was valued at approximately $29.92 billion in 2024. This market is projected to reach about $39.09 billion by 2030, growing at a CAGR of 4.61% from 2025 to 2030. Another estimate for the U.S. hospice market size in 2024 was $30.25 billion, with a projection to reach around $47.52 billion by 2034 at a CAGR of 4.62% from 2025 to 2034. The market size for Hospices & Palliative Care Centers in the U.S. is estimated at $39.0 billion in 2025.

Senior Living Services

The addressable market for senior living services in the U.S. exhibits a range of estimates. One source estimated the U.S. senior living market size at $907.59 billion in 2024, with an expectation to reach $1.33 trillion by 2033, growing at a CAGR of 4.42% from 2025 to 2033. Another report valued the U.S. senior living market at $923.20 billion in 2023, projecting growth to approximately $1.22 trillion by 2030 at a CAGR of 4.16%. Other estimates place the U.S. senior living market at around $111.20 billion in 2024, with a projection to reach approximately $201.03 billion by 2034 at a CAGR of 6.10% between 2025 and 2034. Pennant's offerings in this segment include residential accommodations, activities, meals, housekeeping, and assistance with daily living for independent seniors or those requiring some support.

Here are 3-5 expected drivers of future revenue growth for Pennant (PNTG) over the next 2-3 years:

1. Acquisitions and Strategic Expansion: Pennant consistently pursues strategic acquisitions to expand its market presence and operational capabilities. A significant recent example is the acquisition of 54 operations from UnitedHealth Group and Amedisys in October 2025, which is expected to serve as a platform for growth in the Southeastern United States. The company continues to evaluate additional acquisition opportunities.
2. Organic Growth in Home Health and Hospice Services: The Home Health and Hospice segment is a primary revenue driver, accounting for a substantial portion of Pennant's total revenue. Future growth is anticipated through increased patient admissions and a rising average daily census within these services.
3. Occupancy Growth and Pricing in Senior Living Services: Revenue growth in the Senior Living segment is expected to be fueled by incremental occupancy gains in its communities and an increase in the average monthly revenue per occupied room.
4. Demographic Tailwinds: The increasing senior population in the United States acts as a significant demographic tailwind, supporting organic growth and driving higher utilization rates across Pennant's senior care segments.
5. Operational Efficiencies and Margin Expansion: While primarily impacting profitability, improved operational efficiencies resulting from the scaling of operations and investments in technology are expected to contribute to higher profit margins. This enhanced efficiency and profitability can support sustained revenue growth and provide capital for further expansion.

Share Repurchases

• On December 13, 2022, The Pennant Group announced a share repurchase program authorized to repurchase common stock, which expired on December 12, 2023.
• This program was intended to allow opportunistic investment in the company's stock when it was undervalued.
• As of September 30, 2025, and December 31, 2024, treasury stock at cost remained at $65,000, representing 3 shares.

Share Issuance

• The Pennant Group has diluted its shareholders, with the share count increasing by 16.6% over a five-year period.
• The issuance of common stock from the exercise of options resulted in $909,000 for the nine months ended September 30, 2025, and $2,019,000 for the nine months ended September 30, 2024.
• A Q1 2025 equity offering positively impacted the company's financial performance.

Outbound Investments

• Pennant has made a total of 14 acquisitions, with significant activity in 2020 (4 acquisitions), 2023 (3 acquisitions), and 2025 (2 acquisitions as of September).
• On October 1, 2025, Pennant completed the acquisition of 54 home health, hospice, and personal care operations from UnitedHealth Group and Amedisys for $146.5 million, primarily in Tennessee, Alabama, and Georgia.
• In November 2025, Pennant acquired operations and real property for a 55-bed assisted living community in Lewiston, Idaho (Twin Rivers Senior Living) and completed the purchase of real property for Honey Creek Heights Senior Living in West Allis, Wisconsin, adding 135 beds.

Capital Expenditures

• Net cash used in investing activities, which includes capital expenditures and acquisitions, was $(74,950) thousand for the nine months ended September 30, 2025, and $(66,287) thousand for the nine months ended September 30, 2024.
• Capital expenditures reflected in accounts payable and accrued liabilities amounted to $1,076,000 for the nine months ended September 30, 2025, and $1,630,000 for the nine months ended September 30, 2024.
• The primary focus of capital allocation, including capital expenditures, is to drive organic growth and acquire additional home health, hospice, and senior living operations in existing and new markets.